Researchers investigate the link between cognitive function and levels of a vital eye pigment linked to diet.
A new study reports that a new gene therapy shows promise in treating dry age-related macular degeneration. The gene therapy, ophNdi1, directly targets mitochondrial function that is malfunctioning in AMD.
Researchers have developed a new experimental human cell line from retinal pigment epithelial cells, dubbed ABC cells, that can assist with the study of blinding eye diseases, including age-related macular degeneration.
A new study reveals a considerable link between three common eye diseases and an increased risk of developing Alzheimer's disease. Researchers believe their findings could help physicians better detect those at risk of developing dementia.
A new study reports the dietary supplement Omega 3 does not slow cognitive decline in older people, especially if they already have preexisting cognitive problems.
Cognitive tests that rely on vision-dependent tasks may skew results for up to 25% of adults over 50 with undiagnosed visual problems such as AMD and cataracts. This may lead to a misdiagnosis of mild cognitive impairment in older adults.
Fluoxetine, the antidepressant commonly known as Prozac, may be beneficial for the treatment of age-related macular degeneration. Researchers found Prozac significantly slowed the rate at which people over 50 developed AMD.
Treatment with Humanin G reduced protein levels of inflammation markers that become elevated in age-related macular degeneration.
The AREDS2 dietary supplement that substitutes antioxidants lutein and zeaxanthin for beta-carotene reduces the risk of age-related macular degeneration progression, a new study reveals.
A new study could help explain why our peripheral vision is so poor.